Agfa targets US cardio IT market with Heartlab buy
This article was originally published in Clinica
Agfa-Gevaert is to pay $132.5m in cash for Heartlab, a maker of cardiology image and information networks based in Westerly, Rhode Island. Heartlab had revenues of $38.3m in 2004.
You may also be interested in...
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.
Mylan, in partnership with Indian firm Lupin, will be looking to rival Biogen and Sandoz by introducing an etanercept biosimilar in European markets following a positive opinion by the EMA’s CHMP on Mylan's application.
Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.